SCHEMBL6277867

SCHEMBL6277867

CC(C)=CCOc1c(O)c2cc(OCC(O)CO)ccc2oc1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ MTNR1A P48039 1/20 0.42
▸ GAA P10253 3/20 0.42
▸ MAPT P10636 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ TDP1 Q9NUW8 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ MAOB P27338 2/20 0.41
▸ ALDH2 P05091 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ ALK Q9UM73 4/20 0.41
▸ MGAM O43451 2/20 0.41
▸ SI P14410 2/20 0.41
▸ PTPN1 P18031 2/20 0.41
▸ MGAM2 Q2M2H8 2/20 0.41
▸ NQO1 P15559 1/20 0.41
▸ LMNA P02545 1/20 0.39
▸ ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6277728 0.92 ALDH1A1 (0.49) ALDH1A1KDM4EMTNR1AGAAMAPT
SCHEMBL27599605 0.87 ALK (0.40) ALDH1A1KDM4EGAAHPGDTSHR
SCHEMBL6271379 0.86 NQO1 (0.44) ALDH1A1KDM4EGAAMAPTHPGD
SCHEMBL6272716 0.85 TDP1 (0.46) ALDH1A1KDM4EMTNR1AGAAMAPT
SCHEMBL6270838 0.84 MAOA (0.43) TSHRMAOBALDH2MAOAALK
SCHEMBL6271415 0.83 TDP1 (0.45) ALDH1A1KDM4EMTNR1AGAAMAPT
SCHEMBL6274569 0.82 MGAM (0.51) ALDH1A1KDM4EMTNR1AGAAMAPT
SCHEMBL6274574 0.82 MGAM (0.51) ALDH1A1KDM4EMTNR1AGAAMAPT
SCHEMBL6277196 0.82 ALDH1A1 (0.52) ALDH1A1KDM4EMTNR1AGAAMAPT
SCHEMBL6270825 0.82 CNR2 (0.44) MAOBALDH2MAOAALKNQO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 — — EP disclosed
CN-1473565-A Benzopyrany/derivatives and antiallergic agent ���ձ���ī��ѧ��ʽ���� 2004-02-11 — — CN disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 — — US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 — — US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 ALDH1A1 105/4885KDM4E 965/4885MTNR1A 116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback